TY  - JOUR
AU  - Romero-Garcia, Raquel
AU  - Gomez-Jaramillo, Laura
AU  - Mateos, Rosa Maria
AU  - Jimenez-Gomez, Gema
AU  - Pedreño-Horrillo, Nuria
AU  - Foncubierta, Esther
AU  - Rodriguez-Gutierrez, Juan Francisco
AU  - Garzon, Sebastian
AU  - Mora-Lopez, Francisco
AU  - Rodriguez, Carmen
AU  - Valor, Luis M
AU  - Campos-Caro, Antonio
PY  - 2020
DO  - 10.1038/s41598-020-72946-z
UR  - http://hdl.handle.net/10668/16333
T2  - Scientific reports
AB  - Multiple myeloma (MM) is a B-cell neoplasm that is characterized by the accumulation of malignant plasma cells in the bone marrow. The transcription factor PRDM1 is a master regulator of plasma cell development and is considered to be an...
LA  - en
PB  - Nature Publishing Group
KW  - Área de Gestión Sanitaria de Jerez, Costa Noroeste y Sierra de Cádiz
KW  - Apoptosis
KW  - Cell Line, Tumor
KW  - DNA Methylation
KW  - Down-Regulation
KW  - Epigenesis, Genetic
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Multiple Myeloma
KW  - Positive Regulatory Domain I-Binding Factor 1
KW  - Promoter Regions, Genetic
TI  - Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.
TY  - research article
VL  - 10
ER  -